ExploreWatchlistsPricing
  1. US-listed companies
  2. Atara Biotherapeutics, Inc.
  3. Financials
  4. Return on Assets

Atara Biotherapeutics, Inc. (ATRA)

Market cap
$27.72M
P/E ratio
SummaryFinancials
Period EndReturn on Assets (Million USD)YoY (%)
Dec 31, 2024-62.2-38.97%
Dec 31, 2023-101.9+88.51%
Dec 31, 2022-54.1-16.07%
Dec 31, 2021-64.4-2.20%
Dec 31, 2020-65.9-16.84%
Dec 31, 2019-79.2+4.64%
Dec 31, 2018-75.7+52.57%
Dec 31, 2017-49.6+84.77%
Dec 31, 2016-26.8+1.13%
Dec 31, 2015-26.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat